+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stromal Vascular Fraction - Global Strategic Business Report

  • PDF Icon

    Report

  • 214 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309827
The global market for Stromal Vascular Fraction is estimated at US$93.8 Million in 2023 and is projected to reach US$127.8 Million by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the SVF market is driven by several factors, including advancements in cell isolation technologies and a deepening understanding of regenerative medicine. Increased investment in biotechnology research has propelled the development of more efficient and scalable processing techniques, which are crucial for the wider adoption of SVF-based therapies. Additionally, the growing demand for minimally invasive cosmetic and therapeutic procedures has significantly contributed to the popularity of SVF. The demand for aesthetic & reconstructive therapies continues to grow owing to the never-ending desire of people to look younger and retain youthful appearance, while creating ample opportunities for related markets such as stromal vascular fraction (SVF) treatment method. Regulatory frameworks are also evolving to better accommodate the clinical use of such innovative therapies, thereby encouraging more clinical trials and applications. Moreover, as the general population ages, there is an increasing prevalence of degenerative diseases which can potentially be treated with SVF, thus expanding the target demographic. Together, these elements are key drivers promoting the sustained growth and development of the SVF sector in the biomedical field.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Isolation Products segment, which is expected to reach US$99.5 Million by 2030 with a CAGR of a 4.4%. The Aspiration Products segment is also set to grow at 5.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $30.9 Million in 2023, and China, forecasted to grow at an impressive 5.7% CAGR to reach $9.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Stromal Vascular Fraction Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stromal Vascular Fraction Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Stromal Vascular Fraction Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as GE HealthCare PLC, Kyocera Corporation, Stempeutics Research Pvt., Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 25 Featured):

  • GE HealthCare PLC
  • Kyocera Corporation
  • Stempeutics Research Pvt., Ltd.
  • Genesis Biosystems, Inc.
  • IntelliCell BioSciences, Inc.
  • human med AG
  • InGeneron, Inc.
  • iXCells Biotechnologies
  • Jointechlabs, Inc.
  • Froceth
  • GID BIO
  • Obatala Sciences

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Stromal Vascular Fraction - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Stem Cells, Application Areas, and the Different Types: A Prelude
  • Applications of Stem Cells
  • Types of Stem Cells
  • Stromal Vascular Fraction: An Introduction
  • Production Method for SVF
  • SVF Cell Procedure
  • SVF Composition, Content, and Source
  • SVF: Mechanism of Action
  • SVF: Clinical Applications
  • Safety and Efficiency of SVF
  • Clinical Trials and Regulations Related to SVF
  • Limitations and Scope
  • GLOBAL MARKET OVERVIEW
  • Extensive Therapeutic Scope Set to Stimulate Growth of Global Stromal Vascular Fraction Market
  • Soft Tissue Segment Leads the Market
  • North America Dominates the Global Market, Asia-Pacific to Witness Fastest Growth
  • Lucrative Opportunities & Restraints
  • Market Restraints
  • Salient Drivers Offering Growth Impetus to Stromal Vascular Fraction Market
  • Extensive Application Scope
  • Rising Focus on Non-Enzymatic Isolation Techniques
  • Strong Research Focus on Optimization of Tissue Recovery
  • Consistent Efforts to Develop Better Cell Therapies
  • Competition
  • Players Bet on Product Innovation to Push Footprint in Stromal Vascular Fraction Market
  • Recent Market Activity
  • SVF Isolation Products Continue to Make Gains
  • PIPELINE ANALYSIS
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Regenerative Medicine: A Promising Application of Stromal Vascular Fraction
  • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
  • Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Market Expansion
  • Use of SVF in Osteoarthritis Treatment
  • Surging Demand for Aesthetic & Reconstructive Therapies Enhances Market Prospects
  • Increasing Awareness about Stem Cell Therapy Augurs Well
  • Innovative Methods Become Relevant in Optimizing Tissue Recovery
  • Stromal Vascular Formation Holds Significance for Chronic Diseases
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Stromal Vascular Fraction in Diabetic Care
  • Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
  • Low Temperature Settings Optimize Vitality of Adipose Tissue-derived SVFs
  • SVF Offers Helpful Microenvironment to Regulate ASC Activity under Specific Clinical Conditions
  • Swift Influx of Stem Cell Therapies Requires Alternate Regulatory Pathway Covering Autologous SVF
  • The Counterview
  • Contrast with Regulatory Framework Covering HCT/Ps
  • Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Stromal Vascular Fracture
  • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
  • High Incidence of Neurological Disorders: A Key Market Driver
  • Annual Incidence of Adult-Onset Neurologic Disorders in the US
  • Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
  • Increase in Healthcare Spending Stirs Demand for Stromal Vascular Formation
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Expansion of Private Hospitals in Rural Areas
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Isolation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World 7-Year Perspective for Isolation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Aspiration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 4: World 7-Year Perspective for Aspiration Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Transfer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World 7-Year Perspective for Transfer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Soft Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World 7-Year Perspective for Soft Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Cosmetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 10: World 7-Year Perspective for Cosmetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World 7-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 16: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World 7-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Stem Cell Banks/Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World 7-Year Perspective for Stem Cell Banks/Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 21: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 22: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 23: World Stromal Vascular Fraction Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030
  • Table 24: World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 25: World 7-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: USA 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 29: USA 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 30: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 31: USA 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 34: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 35: Canada 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 36: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 37: Canada 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
JAPAN
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 40: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 41: Japan 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 42: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 43: Japan 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
CHINA
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: China 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 46: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 47: China 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 48: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 49: China 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
EUROPE
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 53: Europe 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 54: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 55: Europe 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 57: Europe 7-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
FRANCE
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 58: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 59: France 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 60: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 61: France 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 62: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: France 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
GERMANY
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 64: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 65: Germany 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 66: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 67: Germany 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 68: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
ITALY
  • Table 70: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 71: Italy 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 72: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 73: Italy 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 74: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
UNITED KINGDOM
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 76: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 77: UK 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 78: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 79: UK 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 80: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: UK 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
REST OF EUROPE
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 83: Rest of Europe 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 84: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 85: Rest of Europe 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of Europe 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
ASIA-PACIFIC
  • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 89: Asia-Pacific 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 91: Asia-Pacific 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Asia-Pacific 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
REST OF WORLD
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 95: Rest of World 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2024 & 2030
  • Table 96: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 97: Rest of World 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2024 & 2030
  • Table 98: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of World 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • GE HealthCare PLC
  • Kyocera Corporation
  • Stempeutics Research Pvt., Ltd.
  • Genesis Biosystems, Inc.
  • IntelliCell BioSciences, Inc.
  • human med AG
  • InGeneron, Inc.
  • iXCells Biotechnologies
  • Jointechlabs, Inc.
  • Froceth
  • GID BIO
  • Obatala Sciences

Table Information